BAM vs IVZ

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 11, 2026

BAM

32.9
AI Score
VS
IVZ Wins

IVZ

68.5
AI Score

Investment Advisor Scores

BAM

33score
Recommendation
EXTENDED

IVZ

69score
Recommendation
STRONG BUY

AI Analyst Insights

Detailed Metrics Comparison

Metric BAM IVZ Winner
Forward P/E 24.8756 8.4104 IVZ
PEG Ratio 0.9423 0.9008 IVZ
Revenue Growth 71.6% 14.2% BAM
Earnings Growth 272.7% -1.5% BAM
Tradestie Score 32.9/100 68.5/100 IVZ
Profit Margin 71.2% -1.1% BAM
Beta 1.00 1.00 Tie
AI Recommendation EXTENDED STRONG BUY IVZ

Relative Price Performance (Last 90 Days)

BAM 1M: +16.7% · 3M: -1.9% IVZ 1M: -1.3% · 3M: -8.5%

Current Technical Phase

BAM

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 68

RSI (14): 67.7 · Price: $53.49

IVZ

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 50

RSI (14): 50.0 · Price: $28.87

Fundamentals Snapshot

Metric BAM IVZ
Market Cap — —
Forward P/E 24.8 8.8
Trailing P/E 18.4 —
Revenue (TTM) — —
Revenue Growth 0.7% 0.1%
Gross Margin 0.8% 0.3%
Operating Margin 0.7% 0.2%
EPS 2.95 -0.69
Dividend Yield 0.04% 0.03%

Frequently Asked Questions

Based on our detailed analysis, IVZ is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.